TSE:TST

Telesta Therapeutics (TST) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
292,300 shs
Average Volume
212,584 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Telesta Therapeutics

Telesta Therapeutics Inc. is a human therapeutics company. The Company is a biotechnology company, which is focused on the licensing/acquisition and development of transformational therapeutics for the treatment of human diseases, such as cancer, immune diseases and targeted rare diseases. The Company focuses on developing drug candidate, Mycobacterium phlei cell wall-nucleic acid complex (MCNA) for the treatment of non-muscle invasive bladder cancer. The Company owns a manufacturing facility for MCNA at Montreal, Quebec. The Company has not generated any revenues.

TST Stock News Headlines

Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
Mercantile Inv Tst : Ten Largest Investments
Rams-Chargers instant reaction podcast
Schroder Br.Opps.Tst : Director/PDMR Shareholding
See More Headlines
Receive TST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Telesta Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Electronic Computer Manufacturing
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

TST Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Telesta Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Telesta Therapeutics investors own include Bombardier, Inc. Class B (BBD.B), Big Banc Split (BNK), Juno Therapeutics (JUNO), KalVista Pharmaceuticals (KALV), ProMetic Life Sciences (PLI), Petrowest (PRW), Sequans Communications (SQNS), BioLineRx (BLRX) and Bausch Health Companies (BHC).

How do I buy shares of Telesta Therapeutics?

Shares of TST stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:TST) was last updated on 5/5/2024 by MarketBeat.com Staff

From Our Partners